Moderna, Inc. - COMMON STOCK (MRNA)

Historical Holders from Q4 2018 to Q3 2025

Symbol
MRNA on Nasdaq
CUSIP
60770K107
Type / Class
Equity / COMMON STOCK
Shares outstanding
385M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
274M
Holdings value
$7.09B
% of all portfolios
0.005%
Grand Portfolio weight change
-0.001%
Number of holders
612
Number of buys
253
Number of sells
-312
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Moderna, Inc. - COMMON STOCK (MRNA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BAILLIE GIFFORD & CO 6.5% -36% $665M -$372M 24.9M -35.8% BAILLIE GIFFORD & CO Mar 31, 2025
FMR LLC 3.2% -38.3% $318M -$228M 12.3M -41.8% FMR LLC Sep 30, 2025

Institutional Holders of Moderna, Inc. - COMMON STOCK (MRNA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 274M $7.09B -$450M $25.83 612
2025 Q2 291M $8.04B +$363M $27.59 660
2025 Q1 279M $7.9B -$59.3M $28.35 675
2024 Q4 277M $11.5B +$498M $41.58 721
2024 Q3 257M $17.1B -$821M $66.83 765
2024 Q2 262M $31.1B +$416M $118.75 937
2024 Q1 259M $27.6B +$210M $106.56 890
2023 Q4 927K $92.1M +$8.55M $99.45 21
2023 Q3 243M $25.1B -$391M $103.29 850
2023 Q2 244M $29.6B -$850M $121.50 926
2023 Q1 245M $37.6B +$87.6M $153.58 976
2022 Q4 248M $44.5B +$357M $179.62 1,029
2022 Q3 242M $28.6B +$337M $118.25 857
2022 Q2 244M $34.8B -$410M $142.85 940
2022 Q1 245M $42.2B +$557M $172.26 963
2021 Q4 241M $61B +$683M $253.98 1,062
2021 Q3 243M $93.4B +$6.74B $384.86 1,113
2021 Q2 208M $48.8B +$5.17B $234.98 866
2021 Q1 189M $24.7B +$2.71B $130.95 753
2020 Q4 168M $17.6B -$523M $104.47 672
2020 Q3 205M $14.5B -$1.02B $70.75 526
2020 Q2 217M $14B +$1.64B $64.21 469
2020 Q1 190M $5.69B +$497M $29.95 274
2019 Q4 169M $3.31B +$261M $19.56 152
2019 Q3 105M $1.68B +$425M $15.92 129
2019 Q2 143M $2.1B +$129M $14.64 125
2019 Q1 138M $2.8B +$99.8M $20.35 101
2018 Q4 134M $2.02B +$2.02B $15.27 74